These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7439246)

  • 1. Pharmacokinetics of naproxen in subjects with normal and impaired renal function.
    Anttila M; Haataja M; Kasanen A
    Eur J Clin Pharmacol; 1980 Oct; 18(3):263-8. PubMed ID: 7439246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of TZU-0460, a new H2-receptor antagonist, in patients with impaired renal function.
    Takabatake T; Ohta H; Yamamoto Y; Ishida Y; Hara H; Nakamura S; Ushiogi Y; Satoh S; Hattori N
    Eur J Clin Pharmacol; 1986; 30(6):709-12. PubMed ID: 2876900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.
    Erikson LO; Wåhlin-Boll E; Odar-Cederlöf I; Lindholm L; Melander A
    Eur J Clin Pharmacol; 1989; 36(2):165-74. PubMed ID: 2721541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen, and their acyl glucuronides in humans. Effect of cimetidine.
    Vree TB; Van Den Biggelaar-Martea M; Verwey-Van Wissen CP; Vree ML; Guelen PJ
    Br J Clin Pharmacol; 1993 May; 35(5):467-72. PubMed ID: 8512758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function.
    Aweeka F; Jayesekara D; Horton M; Swan S; Lambrecht L; Wilner KD; Sherwood J; Anziano RJ; Smolarek TA; Turncliff RZ
    Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):27S-33S. PubMed ID: 10771451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP; Borsa F; Godin M
    J Antimicrob Chemother; 1983 Jul; 12(1):47-58. PubMed ID: 6619046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of pioglitazone in patients with impaired renal function.
    Budde K; Neumayer HH; Fritsche L; Sulowicz W; Stompôr T; Eckland D
    Br J Clin Pharmacol; 2003 Apr; 55(4):368-74. PubMed ID: 12680885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of temocillin in patients with normal and impaired renal function.
    Boelaert J; Daneels R; Schurgers M; Lambert AM; Van Landuyt HW; Mellows G; Wolf J; Swaisland AJ
    J Antimicrob Chemother; 1983 Apr; 11(4):349-56. PubMed ID: 6853404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients.
    Rouan MC; Binswanger U; Bammatter F; Theobald W; Schoeller JP; Guibert J
    J Antimicrob Chemother; 1984 Jun; 13(6):611-8. PubMed ID: 6088464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of remoxipride and metabolites in patients with various degrees of renal function.
    Movin-Osswald G; Boelaert J; Hammarlund-Udenaes M; Nilsson LB
    Br J Clin Pharmacol; 1993 Jun; 35(6):615-22. PubMed ID: 8329289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Elimination half-life and serum protein binding of the anti-rheumatism agent naproxen in kidney failure].
    Held H
    Z Rheumatol; 1979; 38(3-4):111-9. PubMed ID: 442840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and metabolism of naproxen in children.
    Kauffmann RE; Bolliger RO; Wan SH; Oren J
    Dev Pharmacol Ther; 1982; 5(3-4):143-50. PubMed ID: 7151646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefadroxil in normal subjects and in patients with renal insufficiency.
    Humbert G; Leroy A; Fillastre JP; Godin M
    Chemotherapy; 1979; 25(4):189-95. PubMed ID: 456077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of metronidazole in patients with varying degrees of renal failure.
    Houghton GW; Dennis MJ; Gabriel R
    Br J Clin Pharmacol; 1985 Feb; 19(2):203-9. PubMed ID: 3986078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose pharmacokinetics of pravastatin and metabolites in patients with renal impairment.
    Halstenson CE; Triscari J; DeVault A; Shapiro B; Keane W; Pan H
    J Clin Pharmacol; 1992 Feb; 32(2):124-32. PubMed ID: 1613121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of carteolol in relation to renal function.
    Hasenfuss G; Schäfer-Korting M; Knauf H; Mutschler E; Just H
    Eur J Clin Pharmacol; 1985; 29(4):461-5. PubMed ID: 4092726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
    Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics in renal disease.
    Levy G
    Am J Med; 1977 Apr; 62(4):461-5. PubMed ID: 851113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of tenoxicam in patients with impaired renal function.
    Horber FF; Guentert TW; Weidekamm E; Heizmann P; Descoeudres C; Frey FJ
    Eur J Clin Pharmacol; 1986; 29(6):697-701. PubMed ID: 3709612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.